… Ngaage DL, Bland JM: Lessons from aprotinin: is the routine use and inconsistent dosing
of tranexamic acid prudent? Meta-analysis of randomised and large matched observational …

… Tranexamic acid is a synthetic derivative of lysine that exerts … Tranexamic acid is available
in intravenous and oral formulations. … Tranexamic acid when compared to similar compounds, …

… with massive bleedings using tranexamic acid was presented, … survival was increased when
tranexamic acid was given early … In summary, we consider tranexamic acid is a drug of great …

… from small trials suggests that tranexamic acid may reduce the … Tranexamic acid is an
antifibrinolytic drug, 9 and trials have not been large enough to establish whether tranexamic acid …

… Medical therapy is usually considered a first-line … of tranexamic acid in the treatment of
idiopathic HMB. We searched for medical literature published in English on tranexamic acid from …

… Tranexamic acid appears to be a reasonable adjunct for the emergency medicine clinician to
… does not endorse routine use of any specific medication therapy for ACEI-AE due to lack of …

… We review the evidence for tranexamic acid (TXA) for the treatment and prevention of bleeding
caused by surgery, trauma and bleeding disorders. We highlight therapeutic areas where …

… We hypothesized that tranexamic acid, an antifibrinolytic agent … Therefore, we assessed
the effects of tranexamic acid on … This medical therapy is effective; recurrence of CSDH is rare …

… Tranexamic acid (TA) is an antifibrinolytic drug currently used … medical therapy for hemoptysis,
other than treatment of the specific cause (eg, antibiotics for infection). Tranexamic acid (…

… loss occurred during tranexamic acid therapy in women with … Tranexamic acid significantly
reduced mean blood losses … Clinical benefit has also been reported with tranexamic acid …